nodes	percent_of_prediction	percent_of_DWPC	metapath
Cephalexin—ALB—hematologic cancer	0.125	1	CbGaD
Cephalexin—SLC47A1—Imatinib—hematologic cancer	0.123	0.208	CbGbCtD
Cephalexin—SLC47A1—Mitoxantrone—hematologic cancer	0.0977	0.165	CbGbCtD
Cephalexin—SLC22A8—Mercaptopurine—hematologic cancer	0.033	0.0559	CbGbCtD
Cephalexin—CYP2D6—Lomustine—hematologic cancer	0.0198	0.0335	CbGbCtD
Cephalexin—ALB—Imatinib—hematologic cancer	0.0194	0.0328	CbGbCtD
Cephalexin—CYP2D6—Idarubicin—hematologic cancer	0.0176	0.0298	CbGbCtD
Cephalexin—CYP2D6—Hydroxyurea—hematologic cancer	0.015	0.0254	CbGbCtD
Cephalexin—CYP3A4—Bexarotene—hematologic cancer	0.0135	0.0229	CbGbCtD
Cephalexin—CYP2D6—Bortezomib—hematologic cancer	0.013	0.0221	CbGbCtD
Cephalexin—ALB—Prednisone—hematologic cancer	0.0128	0.0216	CbGbCtD
Cephalexin—CYP3A4—Lomustine—hematologic cancer	0.0126	0.0213	CbGbCtD
Cephalexin—CYP3A4—Busulfan—hematologic cancer	0.0126	0.0213	CbGbCtD
Cephalexin—ALB—Irinotecan—hematologic cancer	0.0121	0.0205	CbGbCtD
Cephalexin—CYP3A4—Thiotepa—hematologic cancer	0.0112	0.019	CbGbCtD
Cephalexin—SLC22A8—Methotrexate—hematologic cancer	0.0108	0.0183	CbGbCtD
Cephalexin—CYP2D6—Imatinib—hematologic cancer	0.00956	0.0162	CbGbCtD
Cephalexin—CYP3A4—Methoxsalen—hematologic cancer	0.00872	0.0148	CbGbCtD
Cephalexin—CYP2D6—Nilotinib—hematologic cancer	0.00869	0.0147	CbGbCtD
Cephalexin—CYP2D6—Vinorelbine—hematologic cancer	0.00861	0.0146	CbGbCtD
Cephalexin—CYP3A4—Bortezomib—hematologic cancer	0.0083	0.014	CbGbCtD
Cephalexin—CYP3A4—Daunorubicin—hematologic cancer	0.00793	0.0134	CbGbCtD
Cephalexin—SLC22A6—Methotrexate—hematologic cancer	0.00753	0.0127	CbGbCtD
Cephalexin—CYP3A4—Cytarabine—hematologic cancer	0.007	0.0118	CbGbCtD
Cephalexin—CYP3A4—Teniposide—hematologic cancer	0.00689	0.0117	CbGbCtD
Cephalexin—ALB—Methotrexate—hematologic cancer	0.00641	0.0108	CbGbCtD
Cephalexin—CYP3A4—Ifosfamide—hematologic cancer	0.00636	0.0108	CbGbCtD
Cephalexin—CYP3A4—Imatinib—hematologic cancer	0.00608	0.0103	CbGbCtD
Cephalexin—CYP3A4—Ruxolitinib—hematologic cancer	0.00572	0.00968	CbGbCtD
Cephalexin—CYP3A4—Nilotinib—hematologic cancer	0.00552	0.00934	CbGbCtD
Cephalexin—CYP3A4—Vinorelbine—hematologic cancer	0.00548	0.00927	CbGbCtD
Cephalexin—CYP2D6—Vinblastine—hematologic cancer	0.00531	0.00898	CbGbCtD
Cephalexin—CYP3A4—Triamcinolone—hematologic cancer	0.00501	0.00847	CbGbCtD
Cephalexin—CYP3A4—Dasatinib—hematologic cancer	0.00488	0.00826	CbGbCtD
Cephalexin—CYP3A4—Mitoxantrone—hematologic cancer	0.00482	0.00816	CbGbCtD
Cephalexin—CYP3A4—Betamethasone—hematologic cancer	0.0043	0.00727	CbGbCtD
Cephalexin—CYP3A4—Prednisolone—hematologic cancer	0.00424	0.00717	CbGbCtD
Cephalexin—CYP3A4—Prednisone—hematologic cancer	0.004	0.00677	CbGbCtD
Cephalexin—CYP2D6—Dexamethasone—hematologic cancer	0.00393	0.00665	CbGbCtD
Cephalexin—CYP3A4—Irinotecan—hematologic cancer	0.0038	0.00642	CbGbCtD
Cephalexin—CYP3A4—Vinblastine—hematologic cancer	0.00338	0.00571	CbGbCtD
Cephalexin—CYP3A4—Vincristine—hematologic cancer	0.00332	0.00561	CbGbCtD
Cephalexin—CYP2D6—Doxorubicin—hematologic cancer	0.00326	0.00552	CbGbCtD
Cephalexin—CYP3A4—Etoposide—hematologic cancer	0.00304	0.00514	CbGbCtD
Cephalexin—CYP3A4—Dexamethasone—hematologic cancer	0.0025	0.00423	CbGbCtD
Cephalexin—CYP3A4—Doxorubicin—hematologic cancer	0.00207	0.00351	CbGbCtD
Cephalexin—Cefazolin—PON1—hematologic cancer	0.00072	0.381	CrCbGaD
Cephalexin—SLC47A1—hematopoietic system—hematologic cancer	0.000525	0.0984	CbGeAlD
Cephalexin—SLC22A8—hematopoietic system—hematologic cancer	0.000403	0.0755	CbGeAlD
Cephalexin—SLC47A1—gonad—hematologic cancer	0.000399	0.0748	CbGeAlD
Cephalexin—SLC47A1—blood—hematologic cancer	0.000348	0.0652	CbGeAlD
Cephalexin—SLC47A1—lung—hematologic cancer	0.000305	0.0571	CbGeAlD
Cephalexin—Cefdinir—MPO—hematologic cancer	0.000295	0.156	CrCbGaD
Cephalexin—Cefaclor—MPO—hematologic cancer	0.000292	0.154	CrCbGaD
Cephalexin—SLC47A1—testis—hematologic cancer	0.000288	0.0539	CbGeAlD
Cephalexin—SLC22A8—blood—hematologic cancer	0.000267	0.05	CbGeAlD
Cephalexin—SLC15A2—blood—hematologic cancer	0.000232	0.0434	CbGeAlD
Cephalexin—ALB—testis—hematologic cancer	0.00023	0.0431	CbGeAlD
Cephalexin—SLC47A1—lymph node—hematologic cancer	0.000209	0.0391	CbGeAlD
Cephalexin—SLC15A2—lung—hematologic cancer	0.000203	0.0381	CbGeAlD
Cephalexin—SLC22A5—blood—hematologic cancer	0.000202	0.0378	CbGeAlD
Cephalexin—CYP3A4—hematopoietic system—hematologic cancer	0.0002	0.0374	CbGeAlD
Cephalexin—CYP2D6—hematopoietic system—hematologic cancer	0.000196	0.0368	CbGeAlD
Cephalexin—SLC15A2—testis—hematologic cancer	0.000192	0.0359	CbGeAlD
Cephalexin—Cefpiramide—ALB—hematologic cancer	0.00019	0.1	CrCbGaD
Cephalexin—SLC22A5—lung—hematologic cancer	0.000177	0.0331	CbGeAlD
Cephalexin—SLC22A5—testis—hematologic cancer	0.000167	0.0313	CbGeAlD
Cephalexin—ALB—lymph node—hematologic cancer	0.000167	0.0312	CbGeAlD
Cephalexin—Cefonicid—ALB—hematologic cancer	0.000166	0.0875	CrCbGaD
Cephalexin—SLC15A2—lymph node—hematologic cancer	0.000139	0.026	CbGeAlD
Cephalexin—CYP3A4—blood—hematologic cancer	0.000132	0.0248	CbGeAlD
Cephalexin—CYP2D6—blood—hematologic cancer	0.00013	0.0244	CbGeAlD
Cephalexin—SLC22A5—lymph node—hematologic cancer	0.000121	0.0227	CbGeAlD
Cephalexin—CYP2D6—testis—hematologic cancer	0.000108	0.0202	CbGeAlD
Cephalexin—Ampicillin—ALB—hematologic cancer	8.29e-05	0.0438	CrCbGaD
Cephalexin—Cefazolin—ALB—hematologic cancer	8.02e-05	0.0424	CrCbGaD
Cephalexin—Cefalotin—ALB—hematologic cancer	6.66e-05	0.0352	CrCbGaD
Cephalexin—Headache—Carmustine—hematologic cancer	5.56e-05	0.000224	CcSEcCtD
Cephalexin—Rash—Alitretinoin—hematologic cancer	5.54e-05	0.000223	CcSEcCtD
Cephalexin—Nervous system disorder—Dexamethasone—hematologic cancer	5.54e-05	0.000223	CcSEcCtD
Cephalexin—Nervous system disorder—Betamethasone—hematologic cancer	5.54e-05	0.000223	CcSEcCtD
Cephalexin—Agitation—Prednisone—hematologic cancer	5.53e-05	0.000223	CcSEcCtD
Cephalexin—Dermatitis—Alitretinoin—hematologic cancer	5.53e-05	0.000223	CcSEcCtD
Cephalexin—Stevens-Johnson syndrome—Doxorubicin—hematologic cancer	5.53e-05	0.000223	CcSEcCtD
Cephalexin—Thrombocytopenia—Betamethasone—hematologic cancer	5.53e-05	0.000223	CcSEcCtD
Cephalexin—Thrombocytopenia—Dexamethasone—hematologic cancer	5.53e-05	0.000223	CcSEcCtD
Cephalexin—Vomiting—Ifosfamide—hematologic cancer	5.52e-05	0.000223	CcSEcCtD
Cephalexin—Hypersensitivity—Cisplatin—hematologic cancer	5.52e-05	0.000222	CcSEcCtD
Cephalexin—Headache—Alitretinoin—hematologic cancer	5.5e-05	0.000222	CcSEcCtD
Cephalexin—Angioedema—Prednisone—hematologic cancer	5.5e-05	0.000222	CcSEcCtD
Cephalexin—Diarrhoea—Gemcitabine—hematologic cancer	5.5e-05	0.000221	CcSEcCtD
Cephalexin—Nausea—Thalidomide—hematologic cancer	5.49e-05	0.000221	CcSEcCtD
Cephalexin—Dyspepsia—Triamcinolone—hematologic cancer	5.48e-05	0.000221	CcSEcCtD
Cephalexin—Rash—Ifosfamide—hematologic cancer	5.48e-05	0.000221	CcSEcCtD
Cephalexin—Dermatitis—Ifosfamide—hematologic cancer	5.47e-05	0.00022	CcSEcCtD
Cephalexin—Erythema multiforme—Methotrexate—hematologic cancer	5.47e-05	0.00022	CcSEcCtD
Cephalexin—Dizziness—Irinotecan—hematologic cancer	5.45e-05	0.00022	CcSEcCtD
Cephalexin—Urticaria—Etoposide—hematologic cancer	5.45e-05	0.00022	CcSEcCtD
Cephalexin—Haemoglobin—Epirubicin—hematologic cancer	5.44e-05	0.000219	CcSEcCtD
Cephalexin—Abdominal pain—Etoposide—hematologic cancer	5.42e-05	0.000219	CcSEcCtD
Cephalexin—Body temperature increased—Etoposide—hematologic cancer	5.42e-05	0.000219	CcSEcCtD
Cephalexin—Haemorrhage—Epirubicin—hematologic cancer	5.41e-05	0.000218	CcSEcCtD
Cephalexin—Hepatitis—Epirubicin—hematologic cancer	5.41e-05	0.000218	CcSEcCtD
Cephalexin—Vomiting—Vincristine—hematologic cancer	5.38e-05	0.000217	CcSEcCtD
Cephalexin—Urticaria—Prednisolone—hematologic cancer	5.37e-05	0.000217	CcSEcCtD
Cephalexin—Asthenia—Cisplatin—hematologic cancer	5.37e-05	0.000216	CcSEcCtD
Cephalexin—Fatigue—Triamcinolone—hematologic cancer	5.36e-05	0.000216	CcSEcCtD
Cephalexin—Urinary tract disorder—Epirubicin—hematologic cancer	5.34e-05	0.000215	CcSEcCtD
Cephalexin—Rash—Vincristine—hematologic cancer	5.34e-05	0.000215	CcSEcCtD
Cephalexin—Dermatitis—Vincristine—hematologic cancer	5.33e-05	0.000215	CcSEcCtD
Cephalexin—Connective tissue disorder—Epirubicin—hematologic cancer	5.32e-05	0.000214	CcSEcCtD
Cephalexin—Urethral disorder—Epirubicin—hematologic cancer	5.3e-05	0.000214	CcSEcCtD
Cephalexin—Headache—Vincristine—hematologic cancer	5.3e-05	0.000214	CcSEcCtD
Cephalexin—Hepatobiliary disease—Doxorubicin—hematologic cancer	5.27e-05	0.000213	CcSEcCtD
Cephalexin—Nausea—Carmustine—hematologic cancer	5.27e-05	0.000212	CcSEcCtD
Cephalexin—Vomiting—Irinotecan—hematologic cancer	5.24e-05	0.000211	CcSEcCtD
Cephalexin—Vomiting—Mitoxantrone—hematologic cancer	5.24e-05	0.000211	CcSEcCtD
Cephalexin—Immune system disorder—Methotrexate—hematologic cancer	5.22e-05	0.000211	CcSEcCtD
Cephalexin—Nausea—Alitretinoin—hematologic cancer	5.22e-05	0.00021	CcSEcCtD
Cephalexin—Convulsion—Prednisone—hematologic cancer	5.22e-05	0.00021	CcSEcCtD
Cephalexin—Agranulocytosis—Doxorubicin—hematologic cancer	5.2e-05	0.00021	CcSEcCtD
Cephalexin—Rash—Irinotecan—hematologic cancer	5.2e-05	0.00021	CcSEcCtD
Cephalexin—Rash—Mitoxantrone—hematologic cancer	5.2e-05	0.00021	CcSEcCtD
Cephalexin—Dermatitis—Irinotecan—hematologic cancer	5.19e-05	0.000209	CcSEcCtD
Cephalexin—Dermatitis—Mitoxantrone—hematologic cancer	5.19e-05	0.000209	CcSEcCtD
Cephalexin—Headache—Mitoxantrone—hematologic cancer	5.17e-05	0.000208	CcSEcCtD
Cephalexin—Headache—Irinotecan—hematologic cancer	5.17e-05	0.000208	CcSEcCtD
Cephalexin—Nausea—Ifosfamide—hematologic cancer	5.16e-05	0.000208	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Betamethasone—hematologic cancer	5.14e-05	0.000207	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	5.14e-05	0.000207	CcSEcCtD
Cephalexin—Arthralgia—Prednisone—hematologic cancer	5.13e-05	0.000207	CcSEcCtD
Cephalexin—Feeling abnormal—Triamcinolone—hematologic cancer	5.13e-05	0.000207	CcSEcCtD
Cephalexin—Diarrhoea—Cisplatin—hematologic cancer	5.12e-05	0.000206	CcSEcCtD
Cephalexin—Erythema multiforme—Epirubicin—hematologic cancer	5.12e-05	0.000206	CcSEcCtD
Cephalexin—Vomiting—Gemcitabine—hematologic cancer	5.11e-05	0.000206	CcSEcCtD
Cephalexin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	5.09e-05	0.000205	CcSEcCtD
Cephalexin—Mental disorder—Methotrexate—hematologic cancer	5.07e-05	0.000204	CcSEcCtD
Cephalexin—Rash—Gemcitabine—hematologic cancer	5.06e-05	0.000204	CcSEcCtD
Cephalexin—Dermatitis—Gemcitabine—hematologic cancer	5.06e-05	0.000204	CcSEcCtD
Cephalexin—Hypersensitivity—Etoposide—hematologic cancer	5.05e-05	0.000204	CcSEcCtD
Cephalexin—Haemoglobin—Doxorubicin—hematologic cancer	5.03e-05	0.000203	CcSEcCtD
Cephalexin—Headache—Gemcitabine—hematologic cancer	5.03e-05	0.000203	CcSEcCtD
Cephalexin—Nausea—Vincristine—hematologic cancer	5.03e-05	0.000203	CcSEcCtD
Cephalexin—Haemorrhage—Doxorubicin—hematologic cancer	5.01e-05	0.000202	CcSEcCtD
Cephalexin—Hepatitis—Doxorubicin—hematologic cancer	5.01e-05	0.000202	CcSEcCtD
Cephalexin—Hypersensitivity—Prednisolone—hematologic cancer	4.98e-05	0.000201	CcSEcCtD
Cephalexin—Dyspepsia—Dexamethasone—hematologic cancer	4.97e-05	0.0002	CcSEcCtD
Cephalexin—Dyspepsia—Betamethasone—hematologic cancer	4.97e-05	0.0002	CcSEcCtD
Cephalexin—Urinary tract disorder—Doxorubicin—hematologic cancer	4.94e-05	0.000199	CcSEcCtD
Cephalexin—Urticaria—Triamcinolone—hematologic cancer	4.94e-05	0.000199	CcSEcCtD
Cephalexin—Asthenia—Etoposide—hematologic cancer	4.92e-05	0.000198	CcSEcCtD
Cephalexin—Connective tissue disorder—Doxorubicin—hematologic cancer	4.92e-05	0.000198	CcSEcCtD
Cephalexin—Body temperature increased—Triamcinolone—hematologic cancer	4.92e-05	0.000198	CcSEcCtD
Cephalexin—Anaphylactic shock—Prednisone—hematologic cancer	4.92e-05	0.000198	CcSEcCtD
Cephalexin—Urethral disorder—Doxorubicin—hematologic cancer	4.91e-05	0.000198	CcSEcCtD
Cephalexin—Nausea—Irinotecan—hematologic cancer	4.9e-05	0.000197	CcSEcCtD
Cephalexin—Nausea—Mitoxantrone—hematologic cancer	4.9e-05	0.000197	CcSEcCtD
Cephalexin—Immune system disorder—Epirubicin—hematologic cancer	4.89e-05	0.000197	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Betamethasone—hematologic cancer	4.87e-05	0.000196	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Dexamethasone—hematologic cancer	4.87e-05	0.000196	CcSEcCtD
Cephalexin—Fatigue—Betamethasone—hematologic cancer	4.87e-05	0.000196	CcSEcCtD
Cephalexin—Fatigue—Dexamethasone—hematologic cancer	4.87e-05	0.000196	CcSEcCtD
Cephalexin—Pruritus—Etoposide—hematologic cancer	4.85e-05	0.000196	CcSEcCtD
Cephalexin—Nervous system disorder—Prednisone—hematologic cancer	4.82e-05	0.000194	CcSEcCtD
Cephalexin—Skin disorder—Prednisone—hematologic cancer	4.77e-05	0.000192	CcSEcCtD
Cephalexin—Nausea—Gemcitabine—hematologic cancer	4.77e-05	0.000192	CcSEcCtD
Cephalexin—Vomiting—Cisplatin—hematologic cancer	4.76e-05	0.000192	CcSEcCtD
Cephalexin—Mental disorder—Epirubicin—hematologic cancer	4.74e-05	0.000191	CcSEcCtD
Cephalexin—Erythema multiforme—Doxorubicin—hematologic cancer	4.73e-05	0.000191	CcSEcCtD
Cephalexin—Rash—Cisplatin—hematologic cancer	4.72e-05	0.00019	CcSEcCtD
Cephalexin—Dermatitis—Cisplatin—hematologic cancer	4.72e-05	0.00019	CcSEcCtD
Cephalexin—Diarrhoea—Etoposide—hematologic cancer	4.69e-05	0.000189	CcSEcCtD
Cephalexin—Feeling abnormal—Dexamethasone—hematologic cancer	4.65e-05	0.000187	CcSEcCtD
Cephalexin—Feeling abnormal—Betamethasone—hematologic cancer	4.65e-05	0.000187	CcSEcCtD
Cephalexin—Gastrointestinal pain—Dexamethasone—hematologic cancer	4.62e-05	0.000186	CcSEcCtD
Cephalexin—Gastrointestinal pain—Betamethasone—hematologic cancer	4.62e-05	0.000186	CcSEcCtD
Cephalexin—Hypersensitivity—Triamcinolone—hematologic cancer	4.58e-05	0.000185	CcSEcCtD
Cephalexin—Dizziness—Etoposide—hematologic cancer	4.54e-05	0.000183	CcSEcCtD
Cephalexin—Immune system disorder—Doxorubicin—hematologic cancer	4.52e-05	0.000182	CcSEcCtD
Cephalexin—Leukopenia—Methotrexate—hematologic cancer	4.51e-05	0.000182	CcSEcCtD
Cephalexin—Urticaria—Betamethasone—hematologic cancer	4.48e-05	0.000181	CcSEcCtD
Cephalexin—Urticaria—Dexamethasone—hematologic cancer	4.48e-05	0.000181	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Prednisone—hematologic cancer	4.48e-05	0.000181	CcSEcCtD
Cephalexin—Dizziness—Prednisolone—hematologic cancer	4.47e-05	0.00018	CcSEcCtD
Cephalexin—Asthenia—Triamcinolone—hematologic cancer	4.46e-05	0.00018	CcSEcCtD
Cephalexin—Abdominal pain—Dexamethasone—hematologic cancer	4.46e-05	0.00018	CcSEcCtD
Cephalexin—Abdominal pain—Betamethasone—hematologic cancer	4.46e-05	0.00018	CcSEcCtD
Cephalexin—Body temperature increased—Betamethasone—hematologic cancer	4.46e-05	0.00018	CcSEcCtD
Cephalexin—Body temperature increased—Dexamethasone—hematologic cancer	4.46e-05	0.00018	CcSEcCtD
Cephalexin—Nausea—Cisplatin—hematologic cancer	4.45e-05	0.000179	CcSEcCtD
Cephalexin—Pruritus—Triamcinolone—hematologic cancer	4.4e-05	0.000177	CcSEcCtD
Cephalexin—Mental disorder—Doxorubicin—hematologic cancer	4.39e-05	0.000177	CcSEcCtD
Cephalexin—Convulsion—Methotrexate—hematologic cancer	4.36e-05	0.000176	CcSEcCtD
Cephalexin—Vomiting—Etoposide—hematologic cancer	4.36e-05	0.000176	CcSEcCtD
Cephalexin—Agitation—Epirubicin—hematologic cancer	4.33e-05	0.000174	CcSEcCtD
Cephalexin—Dyspepsia—Prednisone—hematologic cancer	4.33e-05	0.000174	CcSEcCtD
Cephalexin—Rash—Etoposide—hematologic cancer	4.32e-05	0.000174	CcSEcCtD
Cephalexin—Dermatitis—Etoposide—hematologic cancer	4.32e-05	0.000174	CcSEcCtD
Cephalexin—Headache—Etoposide—hematologic cancer	4.3e-05	0.000173	CcSEcCtD
Cephalexin—Arthralgia—Methotrexate—hematologic cancer	4.29e-05	0.000173	CcSEcCtD
Cephalexin—Rash—Prednisolone—hematologic cancer	4.26e-05	0.000172	CcSEcCtD
Cephalexin—Dermatitis—Prednisolone—hematologic cancer	4.26e-05	0.000172	CcSEcCtD
Cephalexin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	4.26e-05	0.000172	CcSEcCtD
Cephalexin—Fatigue—Prednisone—hematologic cancer	4.24e-05	0.000171	CcSEcCtD
Cephalexin—Headache—Prednisolone—hematologic cancer	4.24e-05	0.000171	CcSEcCtD
Cephalexin—Leukopenia—Epirubicin—hematologic cancer	4.22e-05	0.00017	CcSEcCtD
Cephalexin—Confusional state—Methotrexate—hematologic cancer	4.14e-05	0.000167	CcSEcCtD
Cephalexin—Dizziness—Triamcinolone—hematologic cancer	4.11e-05	0.000166	CcSEcCtD
Cephalexin—Anaphylactic shock—Methotrexate—hematologic cancer	4.11e-05	0.000166	CcSEcCtD
Cephalexin—Convulsion—Epirubicin—hematologic cancer	4.08e-05	0.000165	CcSEcCtD
Cephalexin—Nausea—Etoposide—hematologic cancer	4.07e-05	0.000164	CcSEcCtD
Cephalexin—Feeling abnormal—Prednisone—hematologic cancer	4.05e-05	0.000163	CcSEcCtD
Cephalexin—Asthenia—Dexamethasone—hematologic cancer	4.05e-05	0.000163	CcSEcCtD
Cephalexin—Asthenia—Betamethasone—hematologic cancer	4.05e-05	0.000163	CcSEcCtD
Cephalexin—Nervous system disorder—Methotrexate—hematologic cancer	4.03e-05	0.000162	CcSEcCtD
Cephalexin—Thrombocytopenia—Methotrexate—hematologic cancer	4.02e-05	0.000162	CcSEcCtD
Cephalexin—Gastrointestinal pain—Prednisone—hematologic cancer	4.02e-05	0.000162	CcSEcCtD
Cephalexin—Nausea—Prednisolone—hematologic cancer	4.02e-05	0.000162	CcSEcCtD
Cephalexin—Arthralgia—Epirubicin—hematologic cancer	4.01e-05	0.000162	CcSEcCtD
Cephalexin—Agitation—Doxorubicin—hematologic cancer	4.01e-05	0.000161	CcSEcCtD
Cephalexin—Pruritus—Betamethasone—hematologic cancer	3.99e-05	0.000161	CcSEcCtD
Cephalexin—Pruritus—Dexamethasone—hematologic cancer	3.99e-05	0.000161	CcSEcCtD
Cephalexin—Skin disorder—Methotrexate—hematologic cancer	3.99e-05	0.000161	CcSEcCtD
Cephalexin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	3.98e-05	0.000161	CcSEcCtD
Cephalexin—Vomiting—Triamcinolone—hematologic cancer	3.96e-05	0.000159	CcSEcCtD
Cephalexin—Rash—Triamcinolone—hematologic cancer	3.92e-05	0.000158	CcSEcCtD
Cephalexin—Dermatitis—Triamcinolone—hematologic cancer	3.92e-05	0.000158	CcSEcCtD
Cephalexin—Urticaria—Prednisone—hematologic cancer	3.9e-05	0.000157	CcSEcCtD
Cephalexin—Leukopenia—Doxorubicin—hematologic cancer	3.9e-05	0.000157	CcSEcCtD
Cephalexin—Headache—Triamcinolone—hematologic cancer	3.9e-05	0.000157	CcSEcCtD
Cephalexin—Body temperature increased—Prednisone—hematologic cancer	3.89e-05	0.000157	CcSEcCtD
Cephalexin—Abdominal pain—Prednisone—hematologic cancer	3.89e-05	0.000157	CcSEcCtD
Cephalexin—Confusional state—Epirubicin—hematologic cancer	3.88e-05	0.000156	CcSEcCtD
Cephalexin—Diarrhoea—Dexamethasone—hematologic cancer	3.86e-05	0.000156	CcSEcCtD
Cephalexin—Diarrhoea—Betamethasone—hematologic cancer	3.86e-05	0.000156	CcSEcCtD
Cephalexin—Anaphylactic shock—Epirubicin—hematologic cancer	3.84e-05	0.000155	CcSEcCtD
Cephalexin—Convulsion—Doxorubicin—hematologic cancer	3.78e-05	0.000152	CcSEcCtD
Cephalexin—Nervous system disorder—Epirubicin—hematologic cancer	3.77e-05	0.000152	CcSEcCtD
Cephalexin—Thrombocytopenia—Epirubicin—hematologic cancer	3.76e-05	0.000152	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Methotrexate—hematologic cancer	3.74e-05	0.000151	CcSEcCtD
Cephalexin—Skin disorder—Epirubicin—hematologic cancer	3.73e-05	0.000151	CcSEcCtD
Cephalexin—Dizziness—Dexamethasone—hematologic cancer	3.73e-05	0.00015	CcSEcCtD
Cephalexin—Dizziness—Betamethasone—hematologic cancer	3.73e-05	0.00015	CcSEcCtD
Cephalexin—Arthralgia—Doxorubicin—hematologic cancer	3.71e-05	0.00015	CcSEcCtD
Cephalexin—Nausea—Triamcinolone—hematologic cancer	3.69e-05	0.000149	CcSEcCtD
Cephalexin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	3.69e-05	0.000149	CcSEcCtD
Cephalexin—Hypersensitivity—Prednisone—hematologic cancer	3.62e-05	0.000146	CcSEcCtD
Cephalexin—Dyspepsia—Methotrexate—hematologic cancer	3.62e-05	0.000146	CcSEcCtD
Cephalexin—Vomiting—Dexamethasone—hematologic cancer	3.59e-05	0.000145	CcSEcCtD
Cephalexin—Vomiting—Betamethasone—hematologic cancer	3.59e-05	0.000145	CcSEcCtD
Cephalexin—Confusional state—Doxorubicin—hematologic cancer	3.59e-05	0.000145	CcSEcCtD
Cephalexin—Rash—Dexamethasone—hematologic cancer	3.56e-05	0.000143	CcSEcCtD
Cephalexin—Rash—Betamethasone—hematologic cancer	3.56e-05	0.000143	CcSEcCtD
Cephalexin—Anaphylactic shock—Doxorubicin—hematologic cancer	3.56e-05	0.000143	CcSEcCtD
Cephalexin—Dermatitis—Dexamethasone—hematologic cancer	3.56e-05	0.000143	CcSEcCtD
Cephalexin—Dermatitis—Betamethasone—hematologic cancer	3.56e-05	0.000143	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Methotrexate—hematologic cancer	3.55e-05	0.000143	CcSEcCtD
Cephalexin—Fatigue—Methotrexate—hematologic cancer	3.54e-05	0.000143	CcSEcCtD
Cephalexin—Headache—Dexamethasone—hematologic cancer	3.54e-05	0.000143	CcSEcCtD
Cephalexin—Headache—Betamethasone—hematologic cancer	3.54e-05	0.000143	CcSEcCtD
Cephalexin—Asthenia—Prednisone—hematologic cancer	3.53e-05	0.000142	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Epirubicin—hematologic cancer	3.5e-05	0.000141	CcSEcCtD
Cephalexin—Nervous system disorder—Doxorubicin—hematologic cancer	3.49e-05	0.000141	CcSEcCtD
Cephalexin—Thrombocytopenia—Doxorubicin—hematologic cancer	3.48e-05	0.00014	CcSEcCtD
Cephalexin—Pruritus—Prednisone—hematologic cancer	3.48e-05	0.00014	CcSEcCtD
Cephalexin—Skin disorder—Doxorubicin—hematologic cancer	3.46e-05	0.000139	CcSEcCtD
Cephalexin—Feeling abnormal—Methotrexate—hematologic cancer	3.39e-05	0.000136	CcSEcCtD
Cephalexin—Dyspepsia—Epirubicin—hematologic cancer	3.38e-05	0.000136	CcSEcCtD
Cephalexin—Diarrhoea—Prednisone—hematologic cancer	3.36e-05	0.000136	CcSEcCtD
Cephalexin—Gastrointestinal pain—Methotrexate—hematologic cancer	3.36e-05	0.000135	CcSEcCtD
Cephalexin—Nausea—Dexamethasone—hematologic cancer	3.35e-05	0.000135	CcSEcCtD
Cephalexin—Nausea—Betamethasone—hematologic cancer	3.35e-05	0.000135	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Epirubicin—hematologic cancer	3.32e-05	0.000134	CcSEcCtD
Cephalexin—Fatigue—Epirubicin—hematologic cancer	3.31e-05	0.000134	CcSEcCtD
Cephalexin—Urticaria—Methotrexate—hematologic cancer	3.26e-05	0.000132	CcSEcCtD
Cephalexin—Dizziness—Prednisone—hematologic cancer	3.25e-05	0.000131	CcSEcCtD
Cephalexin—Abdominal pain—Methotrexate—hematologic cancer	3.25e-05	0.000131	CcSEcCtD
Cephalexin—Body temperature increased—Methotrexate—hematologic cancer	3.25e-05	0.000131	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	3.24e-05	0.000131	CcSEcCtD
Cephalexin—Feeling abnormal—Epirubicin—hematologic cancer	3.17e-05	0.000128	CcSEcCtD
Cephalexin—Gastrointestinal pain—Epirubicin—hematologic cancer	3.14e-05	0.000127	CcSEcCtD
Cephalexin—Dyspepsia—Doxorubicin—hematologic cancer	3.13e-05	0.000126	CcSEcCtD
Cephalexin—Vomiting—Prednisone—hematologic cancer	3.13e-05	0.000126	CcSEcCtD
Cephalexin—Rash—Prednisone—hematologic cancer	3.1e-05	0.000125	CcSEcCtD
Cephalexin—Dermatitis—Prednisone—hematologic cancer	3.1e-05	0.000125	CcSEcCtD
Cephalexin—Headache—Prednisone—hematologic cancer	3.08e-05	0.000124	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Doxorubicin—hematologic cancer	3.07e-05	0.000124	CcSEcCtD
Cephalexin—Fatigue—Doxorubicin—hematologic cancer	3.07e-05	0.000124	CcSEcCtD
Cephalexin—Urticaria—Epirubicin—hematologic cancer	3.05e-05	0.000123	CcSEcCtD
Cephalexin—Abdominal pain—Epirubicin—hematologic cancer	3.04e-05	0.000122	CcSEcCtD
Cephalexin—Body temperature increased—Epirubicin—hematologic cancer	3.04e-05	0.000122	CcSEcCtD
Cephalexin—Hypersensitivity—Methotrexate—hematologic cancer	3.03e-05	0.000122	CcSEcCtD
Cephalexin—Asthenia—Methotrexate—hematologic cancer	2.95e-05	0.000119	CcSEcCtD
Cephalexin—Feeling abnormal—Doxorubicin—hematologic cancer	2.93e-05	0.000118	CcSEcCtD
Cephalexin—Nausea—Prednisone—hematologic cancer	2.92e-05	0.000118	CcSEcCtD
Cephalexin—Gastrointestinal pain—Doxorubicin—hematologic cancer	2.91e-05	0.000117	CcSEcCtD
Cephalexin—Pruritus—Methotrexate—hematologic cancer	2.91e-05	0.000117	CcSEcCtD
Cephalexin—Hypersensitivity—Epirubicin—hematologic cancer	2.83e-05	0.000114	CcSEcCtD
Cephalexin—Urticaria—Doxorubicin—hematologic cancer	2.83e-05	0.000114	CcSEcCtD
Cephalexin—Body temperature increased—Doxorubicin—hematologic cancer	2.81e-05	0.000113	CcSEcCtD
Cephalexin—Abdominal pain—Doxorubicin—hematologic cancer	2.81e-05	0.000113	CcSEcCtD
Cephalexin—Diarrhoea—Methotrexate—hematologic cancer	2.81e-05	0.000113	CcSEcCtD
Cephalexin—Asthenia—Epirubicin—hematologic cancer	2.76e-05	0.000111	CcSEcCtD
Cephalexin—Pruritus—Epirubicin—hematologic cancer	2.72e-05	0.00011	CcSEcCtD
Cephalexin—Dizziness—Methotrexate—hematologic cancer	2.72e-05	0.000109	CcSEcCtD
Cephalexin—Diarrhoea—Epirubicin—hematologic cancer	2.63e-05	0.000106	CcSEcCtD
Cephalexin—Hypersensitivity—Doxorubicin—hematologic cancer	2.62e-05	0.000106	CcSEcCtD
Cephalexin—Vomiting—Methotrexate—hematologic cancer	2.61e-05	0.000105	CcSEcCtD
Cephalexin—Rash—Methotrexate—hematologic cancer	2.59e-05	0.000104	CcSEcCtD
Cephalexin—Dermatitis—Methotrexate—hematologic cancer	2.59e-05	0.000104	CcSEcCtD
Cephalexin—Headache—Methotrexate—hematologic cancer	2.57e-05	0.000104	CcSEcCtD
Cephalexin—Asthenia—Doxorubicin—hematologic cancer	2.55e-05	0.000103	CcSEcCtD
Cephalexin—Dizziness—Epirubicin—hematologic cancer	2.54e-05	0.000102	CcSEcCtD
Cephalexin—Pruritus—Doxorubicin—hematologic cancer	2.52e-05	0.000101	CcSEcCtD
Cephalexin—Vomiting—Epirubicin—hematologic cancer	2.44e-05	9.85e-05	CcSEcCtD
Cephalexin—Nausea—Methotrexate—hematologic cancer	2.44e-05	9.84e-05	CcSEcCtD
Cephalexin—Diarrhoea—Doxorubicin—hematologic cancer	2.43e-05	9.81e-05	CcSEcCtD
Cephalexin—Rash—Epirubicin—hematologic cancer	2.42e-05	9.77e-05	CcSEcCtD
Cephalexin—Dermatitis—Epirubicin—hematologic cancer	2.42e-05	9.76e-05	CcSEcCtD
Cephalexin—Headache—Epirubicin—hematologic cancer	2.41e-05	9.71e-05	CcSEcCtD
Cephalexin—Dizziness—Doxorubicin—hematologic cancer	2.35e-05	9.48e-05	CcSEcCtD
Cephalexin—Nausea—Epirubicin—hematologic cancer	2.28e-05	9.2e-05	CcSEcCtD
Cephalexin—Vomiting—Doxorubicin—hematologic cancer	2.26e-05	9.12e-05	CcSEcCtD
Cephalexin—Rash—Doxorubicin—hematologic cancer	2.24e-05	9.04e-05	CcSEcCtD
Cephalexin—Dermatitis—Doxorubicin—hematologic cancer	2.24e-05	9.03e-05	CcSEcCtD
Cephalexin—Headache—Doxorubicin—hematologic cancer	2.23e-05	8.98e-05	CcSEcCtD
Cephalexin—Nausea—Doxorubicin—hematologic cancer	2.11e-05	8.52e-05	CcSEcCtD
Cephalexin—ALB—Transmembrane transport of small molecules—NUP98—hematologic cancer	1.33e-05	0.000461	CbGpPWpGaD
Cephalexin—ALB—Platelet activation, signaling and aggregation—FN1—hematologic cancer	1.32e-05	0.000459	CbGpPWpGaD
Cephalexin—ALB—Metabolism—HDC—hematologic cancer	1.32e-05	0.000457	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—SMPD3—hematologic cancer	1.31e-05	0.000455	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—LCK—hematologic cancer	1.31e-05	0.000453	CbGpPWpGaD
Cephalexin—ALB—Transmembrane transport of small molecules—ADCY7—hematologic cancer	1.29e-05	0.000448	CbGpPWpGaD
Cephalexin—ALB—Transmembrane transport of small molecules—NUP214—hematologic cancer	1.28e-05	0.000445	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—H3F3A—hematologic cancer	1.28e-05	0.000444	CbGpPWpGaD
Cephalexin—SLC15A1—Transmembrane transport of small molecules—ALB—hematologic cancer	1.27e-05	0.000441	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—GATA3—hematologic cancer	1.27e-05	0.00044	CbGpPWpGaD
Cephalexin—ALB—Platelet activation, signaling and aggregation—PIK3CG—hematologic cancer	1.27e-05	0.000439	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—HSPA5—hematologic cancer	1.26e-05	0.000438	CbGpPWpGaD
Cephalexin—ALB—Transmembrane transport of small molecules—ABCG2—hematologic cancer	1.26e-05	0.000436	CbGpPWpGaD
Cephalexin—SLC22A5—Transmembrane transport of small molecules—ALB—hematologic cancer	1.25e-05	0.000434	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—PRKCZ—hematologic cancer	1.25e-05	0.000432	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	1.23e-05	0.000426	CbGpPWpGaD
Cephalexin—CYP3A4—Biological oxidations—GSTP1—hematologic cancer	1.22e-05	0.000425	CbGpPWpGaD
Cephalexin—SLC22A8—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.21e-05	0.000419	CbGpPWpGaD
Cephalexin—CYP3A4—Metapathway biotransformation—GSTP1—hematologic cancer	1.21e-05	0.000419	CbGpPWpGaD
Cephalexin—ALB—Metabolism—CDA—hematologic cancer	1.2e-05	0.000418	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—HDAC2—hematologic cancer	1.16e-05	0.000402	CbGpPWpGaD
Cephalexin—ALB—Metabolism—PC—hematologic cancer	1.16e-05	0.000402	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—ASNS—hematologic cancer	1.15e-05	0.000398	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—DCK—hematologic cancer	1.15e-05	0.000398	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—B3GAT1—hematologic cancer	1.15e-05	0.000398	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—ITGA4—hematologic cancer	1.15e-05	0.000398	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—CD44—hematologic cancer	1.15e-05	0.000398	CbGpPWpGaD
Cephalexin—SLC22A8—Transmembrane transport of small molecules—ALB—hematologic cancer	1.13e-05	0.000392	CbGpPWpGaD
Cephalexin—CYP3A4—Biological oxidations—GSTM1—hematologic cancer	1.13e-05	0.00039	CbGpPWpGaD
Cephalexin—ALB—Metabolism—GBA—hematologic cancer	1.12e-05	0.000389	CbGpPWpGaD
Cephalexin—ALB—Metabolism—SLC35B2—hematologic cancer	1.12e-05	0.000389	CbGpPWpGaD
Cephalexin—ALB—Transmembrane transport of small molecules—TFRC—hematologic cancer	1.12e-05	0.000388	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—IL3—hematologic cancer	1.12e-05	0.000388	CbGpPWpGaD
Cephalexin—ALB—Platelet activation, signaling and aggregation—PIK3CD—hematologic cancer	1.11e-05	0.000386	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—IFNA1—hematologic cancer	1.11e-05	0.000385	CbGpPWpGaD
Cephalexin—CYP3A4—Metapathway biotransformation—GSTM1—hematologic cancer	1.11e-05	0.000385	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—PTPN1—hematologic cancer	1.1e-05	0.000382	CbGpPWpGaD
Cephalexin—ALB—Selenium Micronutrient Network—IL6—hematologic cancer	1.09e-05	0.00038	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—HDC—hematologic cancer	1.09e-05	0.000377	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—RASGRP1—hematologic cancer	1.08e-05	0.000375	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—SYK—hematologic cancer	1.08e-05	0.000374	CbGpPWpGaD
Cephalexin—ALB—Platelet activation, signaling and aggregation—PIK3R1—hematologic cancer	1.05e-05	0.000365	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—IFNA2—hematologic cancer	1.03e-05	0.000359	CbGpPWpGaD
Cephalexin—ALB—Metabolism—MTAP—hematologic cancer	1.02e-05	0.000355	CbGpPWpGaD
Cephalexin—ALB—Platelet activation, signaling and aggregation—JAK2—hematologic cancer	1.02e-05	0.000354	CbGpPWpGaD
Cephalexin—SLC22A6—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.01e-05	0.00035	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—CDA—hematologic cancer	9.95e-06	0.000345	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—GRB2—hematologic cancer	9.73e-06	0.000338	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—PDGFA—hematologic cancer	9.71e-06	0.000337	CbGpPWpGaD
Cephalexin—ALB—Platelet activation, signaling and aggregation—PIK3CB—hematologic cancer	9.7e-06	0.000337	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—PC—hematologic cancer	9.58e-06	0.000332	CbGpPWpGaD
Cephalexin—SLC22A6—Transmembrane transport of small molecules—ALB—hematologic cancer	9.43e-06	0.000327	CbGpPWpGaD
Cephalexin—ALB—Transmembrane transport of small molecules—CYCS—hematologic cancer	9.4e-06	0.000326	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—PHYH—hematologic cancer	9.38e-06	0.000325	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—FTCD—hematologic cancer	9.38e-06	0.000325	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—GMPS—hematologic cancer	9.38e-06	0.000325	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—ABL1—hematologic cancer	9.35e-06	0.000324	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—GBA—hematologic cancer	9.25e-06	0.000321	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—SLC35B2—hematologic cancer	9.25e-06	0.000321	CbGpPWpGaD
Cephalexin—ALB—Metabolism—FHL2—hematologic cancer	9.13e-06	0.000317	CbGpPWpGaD
Cephalexin—ALB—Metabolism—AGRN—hematologic cancer	8.95e-06	0.000311	CbGpPWpGaD
Cephalexin—ALB—Platelet activation, signaling and aggregation—IL2—hematologic cancer	8.91e-06	0.000309	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—HGF—hematologic cancer	8.79e-06	0.000305	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—CSF2—hematologic cancer	8.69e-06	0.000302	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—SMPD3—hematologic cancer	8.58e-06	0.000298	CbGpPWpGaD
Cephalexin—ALB—Metabolism—IDH2—hematologic cancer	8.49e-06	0.000294	CbGpPWpGaD
Cephalexin—ALB—Metabolism—HMMR—hematologic cancer	8.49e-06	0.000294	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—MTAP—hematologic cancer	8.46e-06	0.000293	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—JAK1—hematologic cancer	8.39e-06	0.000291	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—PRKCG—hematologic cancer	8.39e-06	0.000291	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	8e-06	0.000278	CbGpPWpGaD
Cephalexin—ALB—Metabolism—ARNTL—hematologic cancer	7.98e-06	0.000277	CbGpPWpGaD
Cephalexin—ALB—Transmembrane transport of small molecules—ABCB1—hematologic cancer	7.84e-06	0.000272	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—IL2RA—hematologic cancer	7.84e-06	0.000272	CbGpPWpGaD
Cephalexin—ALB—Platelet activation, signaling and aggregation—SRC—hematologic cancer	7.78e-06	0.00027	CbGpPWpGaD
Cephalexin—ALB—Metabolism—CA9—hematologic cancer	7.76e-06	0.000269	CbGpPWpGaD
Cephalexin—ALB—Metabolism—ACP5—hematologic cancer	7.76e-06	0.000269	CbGpPWpGaD
Cephalexin—ALB—Metabolism—NCOR2—hematologic cancer	7.66e-06	0.000266	CbGpPWpGaD
Cephalexin—ALB—Platelet activation, signaling and aggregation—VEGFA—hematologic cancer	7.57e-06	0.000263	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—PDGFB—hematologic cancer	7.56e-06	0.000262	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—FHL2—hematologic cancer	7.54e-06	0.000262	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—ASNS—hematologic cancer	7.5e-06	0.00026	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—DCK—hematologic cancer	7.5e-06	0.00026	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—B3GAT1—hematologic cancer	7.5e-06	0.00026	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—AGRN—hematologic cancer	7.39e-06	0.000256	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—CDK2—hematologic cancer	7.34e-06	0.000255	CbGpPWpGaD
Cephalexin—ALB—Metabolism—IDH1—hematologic cancer	7.3e-06	0.000253	CbGpPWpGaD
Cephalexin—ALB—Metabolism—GSTO1—hematologic cancer	7.22e-06	0.00025	CbGpPWpGaD
Cephalexin—ALB—Metabolism—TXN—hematologic cancer	7.22e-06	0.00025	CbGpPWpGaD
Cephalexin—ALB—Metabolism—ABCC3—hematologic cancer	7.22e-06	0.00025	CbGpPWpGaD
Cephalexin—ALB—Platelet activation, signaling and aggregation—MAPK3—hematologic cancer	7.17e-06	0.000249	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—HDC—hematologic cancer	7.11e-06	0.000247	CbGpPWpGaD
Cephalexin—ALB—Metabolism—SPHK1—hematologic cancer	7.06e-06	0.000245	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—MAPK14—hematologic cancer	7.04e-06	0.000244	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—IDH2—hematologic cancer	7.01e-06	0.000243	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—HMMR—hematologic cancer	7.01e-06	0.000243	CbGpPWpGaD
Cephalexin—ALB—Platelet activation, signaling and aggregation—TGFB1—hematologic cancer	6.95e-06	0.000241	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—FN1—hematologic cancer	6.82e-06	0.000237	CbGpPWpGaD
Cephalexin—ALB—Metabolism—UGT1A1—hematologic cancer	6.79e-06	0.000235	CbGpPWpGaD
Cephalexin—ALB—Metabolism—SLC22A1—hematologic cancer	6.6e-06	0.000229	CbGpPWpGaD
Cephalexin—ALB—Metabolism—CRABP1—hematologic cancer	6.6e-06	0.000229	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—ARNTL—hematologic cancer	6.59e-06	0.000229	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—PIK3CG—hematologic cancer	6.53e-06	0.000226	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—CDA—hematologic cancer	6.5e-06	0.000226	CbGpPWpGaD
Cephalexin—ALB—Metabolism—ALOX5—hematologic cancer	6.43e-06	0.000223	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—PTPN11—hematologic cancer	6.41e-06	0.000222	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—ACP5—hematologic cancer	6.41e-06	0.000222	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—CA9—hematologic cancer	6.41e-06	0.000222	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—NCOR2—hematologic cancer	6.33e-06	0.000219	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—PC—hematologic cancer	6.26e-06	0.000217	CbGpPWpGaD
Cephalexin—ALB—Metabolism—NUP98—hematologic cancer	6.23e-06	0.000216	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—CREBBP—hematologic cancer	6.05e-06	0.00021	CbGpPWpGaD
Cephalexin—ALB—Metabolism—ADCY7—hematologic cancer	6.05e-06	0.00021	CbGpPWpGaD
Cephalexin—ALB—Metabolism—NCOA3—hematologic cancer	6.05e-06	0.00021	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—SLC35B2—hematologic cancer	6.05e-06	0.00021	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—GBA—hematologic cancer	6.05e-06	0.00021	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—IDH1—hematologic cancer	6.03e-06	0.000209	CbGpPWpGaD
Cephalexin—ALB—Metabolism—NUP214—hematologic cancer	6.01e-06	0.000208	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—GSTO1—hematologic cancer	5.96e-06	0.000207	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—TXN—hematologic cancer	5.96e-06	0.000207	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—ABCC3—hematologic cancer	5.96e-06	0.000207	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	5.94e-06	0.000206	CbGpPWpGaD
Cephalexin—ALB—Platelet activation, signaling and aggregation—PIK3CA—hematologic cancer	5.92e-06	0.000205	CbGpPWpGaD
Cephalexin—ALB—Metabolism—ABCG2—hematologic cancer	5.88e-06	0.000204	CbGpPWpGaD
Cephalexin—ALB—Metabolism—MTR—hematologic cancer	5.88e-06	0.000204	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—SPHK1—hematologic cancer	5.83e-06	0.000202	CbGpPWpGaD
Cephalexin—ALB—Metabolism—ENO2—hematologic cancer	5.77e-06	0.0002	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—PIK3CD—hematologic cancer	5.74e-06	0.000199	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—UGT1A1—hematologic cancer	5.6e-06	0.000194	CbGpPWpGaD
Cephalexin—ALB—Metabolism—GSTT1—hematologic cancer	5.6e-06	0.000194	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—MTAP—hematologic cancer	5.53e-06	0.000192	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	5.51e-06	0.000191	CbGpPWpGaD
Cephalexin—ALB—Metabolism—SDC1—hematologic cancer	5.47e-06	0.00019	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—SLC22A1—hematologic cancer	5.45e-06	0.000189	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—CRABP1—hematologic cancer	5.45e-06	0.000189	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—PIK3R1—hematologic cancer	5.42e-06	0.000188	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—ALOX5—hematologic cancer	5.31e-06	0.000184	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—JAK2—hematologic cancer	5.27e-06	0.000183	CbGpPWpGaD
Cephalexin—ALB—Transmembrane transport of small molecules—CREBBP—hematologic cancer	5.24e-06	0.000182	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	5.22e-06	0.000181	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—NUP98—hematologic cancer	5.14e-06	0.000178	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—PIK3CB—hematologic cancer	5e-06	0.000174	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—ADCY7—hematologic cancer	4.99e-06	0.000173	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—NCOA3—hematologic cancer	4.99e-06	0.000173	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—NUP214—hematologic cancer	4.96e-06	0.000172	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	4.93e-06	0.000171	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—FHL2—hematologic cancer	4.93e-06	0.000171	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—ABCG2—hematologic cancer	4.86e-06	0.000169	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—MTR—hematologic cancer	4.86e-06	0.000169	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—AGRN—hematologic cancer	4.83e-06	0.000168	CbGpPWpGaD
Cephalexin—ALB—Platelet activation, signaling and aggregation—AKT1—hematologic cancer	4.83e-06	0.000168	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—ENO2—hematologic cancer	4.76e-06	0.000165	CbGpPWpGaD
Cephalexin—ALB—Metabolism—CD44—hematologic cancer	4.65e-06	0.000161	CbGpPWpGaD
Cephalexin—ALB—Metabolism—NQO1—hematologic cancer	4.65e-06	0.000161	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—GSTT1—hematologic cancer	4.62e-06	0.00016	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—IL2—hematologic cancer	4.59e-06	0.000159	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—IDH2—hematologic cancer	4.58e-06	0.000159	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—HMMR—hematologic cancer	4.58e-06	0.000159	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	4.55e-06	0.000158	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—SDC1—hematologic cancer	4.52e-06	0.000157	CbGpPWpGaD
Cephalexin—ALB—Metabolism—CYCS—hematologic cancer	4.4e-06	0.000153	CbGpPWpGaD
Cephalexin—ALB—Metabolism—HSP90AA1—hematologic cancer	4.37e-06	0.000152	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—ARNTL—hematologic cancer	4.31e-06	0.000149	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—CA9—hematologic cancer	4.19e-06	0.000145	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—ACP5—hematologic cancer	4.19e-06	0.000145	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—NCOR2—hematologic cancer	4.14e-06	0.000143	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—EP300—hematologic cancer	4.12e-06	0.000143	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—SRC—hematologic cancer	4.01e-06	0.000139	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—IDH1—hematologic cancer	3.94e-06	0.000137	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.94e-06	0.000137	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—VEGFA—hematologic cancer	3.9e-06	0.000135	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—GSTO1—hematologic cancer	3.9e-06	0.000135	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—TXN—hematologic cancer	3.9e-06	0.000135	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—ABCC3—hematologic cancer	3.9e-06	0.000135	CbGpPWpGaD
Cephalexin—ALB—Metabolism—GSTP1—hematologic cancer	3.88e-06	0.000135	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—NRAS—hematologic cancer	3.86e-06	0.000134	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—CD44—hematologic cancer	3.84e-06	0.000133	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—NQO1—hematologic cancer	3.84e-06	0.000133	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—SPHK1—hematologic cancer	3.81e-06	0.000132	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.75e-06	0.00013	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—MAPK3—hematologic cancer	3.69e-06	0.000128	CbGpPWpGaD
Cephalexin—ALB—Metabolism—ABCB1—hematologic cancer	3.67e-06	0.000127	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—UGT1A1—hematologic cancer	3.66e-06	0.000127	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—CYCS—hematologic cancer	3.63e-06	0.000126	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	3.61e-06	0.000125	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—TGFB1—hematologic cancer	3.58e-06	0.000124	CbGpPWpGaD
Cephalexin—ALB—Metabolism—GSTM1—hematologic cancer	3.56e-06	0.000124	CbGpPWpGaD
Cephalexin—ALB—Metabolism—NCOR1—hematologic cancer	3.56e-06	0.000124	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—SLC22A1—hematologic cancer	3.56e-06	0.000124	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—CRABP1—hematologic cancer	3.56e-06	0.000124	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—ALOX5—hematologic cancer	3.47e-06	0.00012	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—NUP98—hematologic cancer	3.36e-06	0.000117	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—KRAS—hematologic cancer	3.32e-06	0.000115	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—ADCY7—hematologic cancer	3.26e-06	0.000113	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—NCOA3—hematologic cancer	3.26e-06	0.000113	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—NUP214—hematologic cancer	3.24e-06	0.000112	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—GSTP1—hematologic cancer	3.2e-06	0.000111	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—MTR—hematologic cancer	3.18e-06	0.00011	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—ABCG2—hematologic cancer	3.18e-06	0.00011	CbGpPWpGaD
Cephalexin—ALB—Metabolism—MTHFR—hematologic cancer	3.15e-06	0.000109	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—ENO2—hematologic cancer	3.11e-06	0.000108	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—PIK3CA—hematologic cancer	3.05e-06	0.000106	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—ABCB1—hematologic cancer	3.03e-06	0.000105	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—GSTT1—hematologic cancer	3.02e-06	0.000105	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—SDC1—hematologic cancer	2.95e-06	0.000102	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—TP53—hematologic cancer	2.95e-06	0.000102	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—GSTM1—hematologic cancer	2.94e-06	0.000102	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—NCOR1—hematologic cancer	2.94e-06	0.000102	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—HRAS—hematologic cancer	2.82e-06	9.79e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.78e-06	9.63e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—PIK3CG—hematologic cancer	2.65e-06	9.18e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—MTHFR—hematologic cancer	2.6e-06	9.02e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—NQO1—hematologic cancer	2.51e-06	8.71e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—CD44—hematologic cancer	2.51e-06	8.71e-05	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—AKT1—hematologic cancer	2.49e-06	8.64e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—CREBBP—hematologic cancer	2.45e-06	8.51e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—CYCS—hematologic cancer	2.38e-06	8.24e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	2.36e-06	8.19e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—PIK3CD—hematologic cancer	2.33e-06	8.07e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—PIK3R1—hematologic cancer	2.2e-06	7.62e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—PIK3CG—hematologic cancer	2.19e-06	7.58e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—GSTP1—hematologic cancer	2.09e-06	7.26e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—PIK3CB—hematologic cancer	2.03e-06	7.04e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—CREBBP—hematologic cancer	2.03e-06	7.03e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—ABCB1—hematologic cancer	1.98e-06	6.88e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—GSTM1—hematologic cancer	1.92e-06	6.68e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—NCOR1—hematologic cancer	1.92e-06	6.68e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—PIK3CD—hematologic cancer	1.92e-06	6.66e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—ALB—hematologic cancer	1.9e-06	6.58e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—PIK3R1—hematologic cancer	1.81e-06	6.29e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—PTEN—hematologic cancer	1.75e-06	6.08e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—MTHFR—hematologic cancer	1.7e-06	5.9e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—PIK3CB—hematologic cancer	1.67e-06	5.81e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—EP300—hematologic cancer	1.67e-06	5.8e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—PTEN—hematologic cancer	1.45e-06	5.02e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.43e-06	4.96e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—EP300—hematologic cancer	1.38e-06	4.79e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.32e-06	4.6e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.26e-06	4.36e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—ALB—hematologic cancer	1.24e-06	4.3e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—PIK3CA—hematologic cancer	1.24e-06	4.29e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.19e-06	4.11e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.09e-06	3.8e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—PIK3CA—hematologic cancer	1.02e-06	3.54e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—AKT1—hematologic cancer	1.01e-06	3.5e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—PTEN—hematologic cancer	9.46e-07	3.28e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—EP300—hematologic cancer	9.02e-07	3.13e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—AKT1—hematologic cancer	8.34e-07	2.89e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—PIK3CA—hematologic cancer	6.67e-07	2.32e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—AKT1—hematologic cancer	5.45e-07	1.89e-05	CbGpPWpGaD
